Gastroenterology Research and Practice / 2017 / Article / Tab 1

Research Article

Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors

Table 1

Demographics of study population.

Primary sitePancreasGastrointestinal tract (ileum, stomach, and appendix)Total

Number of pts372764 (M: 26)
Age median (range)59.5 (30–79)57 (21–78)59 (21–79)
Syndrome9 insulinoma9 insulinoma
1 carcinoid syndrome2 carcinoid syndrome3 carcinoid syndrome
1 ZES1 ZES2 ZES
StageI-II: 22I-II: 10I-II: 32
IIIB-IV: 15IIIB-IV: 17IIIB-IV: 32
Ki67 median (range)1.8% (0.1–18.8%)2.3% (0.5–12.4%)1.8% (0.1–18.8%)
GradingG1: 21 (56.8%)G1: 18 (66.7%)G1: 39 (60.9%)
G2: 16 (43.2%)G2: 9 (33.3%)G2: 25 (39.1%)
Follow-upMedian 69.5 months (range: 4–140 months)

ZES: Zollinger-Ellison syndrome.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.